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Abstract
Malaria is the cause of hundreds of thousands of deaths per year, besides putting billions of people at risk of developing 
disease. When it comes to its therapy, the drugs used currently are losing its efficacy due to increase in the frequency 
of resistant strains of the parasite, highlighting the importance for the search of new classes of molecules presenting 
antiplasmodial activity. In the present work, the antiplasmodial activities of five extracts (crude, hexane, chloroform, 
ethyl acetate and methanol) from the flowers of Combretum leprosum are assessed. The method employed for obtaining 
the extracts was silica gel column chromatography, and the techniques used for the analysis of antiplasmodial activity 
(IC50) and citotoxicity (MLD50) were ELISA and MTT respectively, where a selectivity index was calculated after the 
obtaining of these two values. The extract presenting the highest antiplasmodial activity was the chloroform extract 
(IC50= 3.97 µg/mL), however, this extract also presented the higher cytotoxicity (MLD50= 18.12 µg/mL), and therefore 
the extract presenting the best overall activity was the methanolic extract (IS = 18.97). The study demonstrated the 
plant Combretum leprosum has active substances against P. falciparum and therefore is a potential to be explored in 
further pharmacological studies with this parasite.
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Resumo
A malária é responsável por milhares de mortes por ano, além de bilhões de pessoas estarem sob o risco de desenvolvê-
la. Quanto à sua terapia os fármacos utilizados atualmente estão perdendo a eficácia devido ao aumento na frequência 
e cepas resistentes do parasita, e esse fato ressalta a importância da busca por novas classes de moléculas com 
atividade antiplasmodial. O presente estudo objetivou analisar a atividade antiplasmodial de cinco extratos (bruto, 
hexânico, clorofórmico, acético e metanólico) das flores da planta Combretum leprosum. A metodologia empregada 
para a obtenção dos extratos foi a cromatografia em silica gel, e as técnicas empregadas para a análise da atividade 
antiplasmodial (IC50) e citotoxicidade (MDL50), respectivamente, foram ELISA e MTT, sendo calculado um índice 
de seletividade (IS) após a obtenção dos dois valores. O extrato que apresentou a maior atividade antiplasmodial 
foi o clorofórmico (IC50= 3,97 µg/mL), contudo, este apresentou alta citotoxicidade (MDL50= 18,12 µg/mL), e foi 
considerado que o extrato que apresentou o melhor IS foi o do extrato metanólico (IS= 18,97). O estudo demonstrou 
que a planta Combretum leprosum possui substâncias ativas contra Plasmodium falciparum e, portanto, constitui-se 
em um potencial a ser explorado em estudos farmacológicos posteriores com este parasita.
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1 Introdution
Over 3 billion people are estimated to be at risk of being infected with malaria and therefore developing dise-
ase, and according to latest estimates, hundreds of thousands of deaths caused by it occurred in each year of this 
millennium (WHO, 2014). The world region that suffers the heaviest burden is Africa, where the great majority of 
cases of malaria occur, mainly in children under the age of five (WHO, 2014). The disease is caused by parasitic 
protozoa of the genus Plasmodium, of which five species are known to infect humans: P. falciparum, P. vivax, P. ma-
lariae, P. ovale, and P. knowlesi (COX, 2010). The parasite life cycle begins when a female mosquito of Anopheles genus 
bites a human and releases the sporozoites from its salivary glands to the dermis, where they reach the avascular 
tissue and then a percentage of them migrates and enters the blood vessels, making their way to the liver, where 
they undergo cellular modifications and perform rounds of asexual replication (ALY; VAUGHAN; KAPPE, 2009). 
After leaving the liver, the parasite begins other cycles of asexual replication inside red blood cells, using mole-
cules and cellular structures of the host cells to survive, grow and reproduce, generating thousands of merozoites 
and causing the characteristic symptoms of the disease (TILLEY; DIXON; KIRK, 2011). When it comes to its che-
motherapy, most of the cases of uncomplicated malaria are treated currently by the use of ACT’s drugs, although is 
already known that these drugs are losing its efficacy due to the increase in frequency of resistant strains (VISSER; 
VUGT; GROBUSCH, 2014), which highlights the importance for the search of new molecules bearing antiplasmo-
dial activity.
Plants have been used during millennia by humanity, and pharmacological studies of medicinal plants yielded 
useful molecules in the treatment of various diseases, including malaria (GINSBURG; DEHARO, 2011), and despite 
the great number of existing species of plants, just a small percentage of them have been characterized pharmaco-
logically, making the biodiversity of world’s flora a great potential to be explored (DERDA; HADÁS, 2015). Data in 
literature show that over 1200 species of plants, belonging to 160 families, are used to treat malaria and fever, and 
on average, a fifth of the patients with malaria in endemic countries use traditional medicines to treat the disease 
(WILLCOX; BODEKER, 2004).
Combretum leprosum is a scandent shrub or liana plant that can be found in Brazil, Paraguay and Bolivia. Some of 
the distinctive features of the species are the opposite leaves, 4-winged fruit and panicle inflorescences (LOIOLA et 
al., 2009). Local populations in the northeast region of Brazil use some of its parts as expectorants, to treat coughs 
and to staunch blood flow (AGRA et al., 2007; SILVA; BARROS; NETO, 2015). In this context, The aim of this study 
is to assess the antiplasmodial potential of C. leprosum flower extracts against P. falciparum in vitro.
2 Material and Methods
Obtaining and preparation of the extracts
Flowers of C. leprosum were collected in Viçosa, State of Ceará, in May 2001. They were properly dried and grinded 
and after dipped in ethanol (99%) for the extraction. The drying of the extract was performed by rota-evaporation 
and part of it was subjected to a chromatographic column with silica gel as standing phase (SASIDHARAN et al., 
2011), whereas the other part constituted the crude extract (CLCrE). The solvents used were hexane, chloroform, 
ethyl acetate and methanol for the obtaining of the following extracts: Hexane extract (CLHE); Chloroform extract 
(CLClE); Ethyl Acetate extract (CLEAE) and methanol extract (CLME). For the carrying out of cytotoxic and anti-
plasmodial tests, extracts were solubilized with ethanol, where all solutions were performed at the moment of the 
biological experiments.
In vitro Antiplasmodial tests against P. falciparum
The chloroquine-resistant strain (W2) was cultured in human red blood cells as established by Trager and Jensen 
(1976) with modifications, using a protocol previously established and standardized by Laboratório de Malária do 
Centro de Pesquisas René Rachou (DE ANDRADE-NETO et al., 2004). The predominance of rings in the culture 
was accomplished by using sorbitol, according to literature (LAMBROS; VANDERBERG, 1979), and the hematocrite 
and parasitemia adjusted by the addition of red blood cells. Culture of synchronized parasites was distributed in 
microplates containing culture medium and red blood cells. Before the addition of the parasites, the drugs were 
added in serial dilutions. For the negative control, no drug was added to the infected red blood cells, and for the 
positive control, chloroquine was added to the parasite culture.  In the ELISA test (NOEDL et al., 2002), two plates 
were prepared: one of them (the test plate) containing the parasites and drugs, and the other one containing the 
antibodies. The test plate was incubated for 72 hours, wherein the negative control was withdrawn 24 hours for 
86 Passarini et al. : In vitro antiplasmodial activity...
being used as background. After 72 hours, the plates were frozen and thawed twice for the lysis of the red blood 
cells. For the sensibilization of the test plates, the primary antibody was added (MPFM-55A ICLLAB®, EUA). Wells 
were washed and incubated, and for each well was added 100 μL of the samples of P. falciparum hemolyzed culture 
and at six wells of the plates corresponding to the background was added 100μL of negative controls. The plate was 
incubated during one hour in moist chamber and washed three times, adding to each well 100μL of the secondary 
antibody (MPFG55P ICLLAB®, EUA). After incubation in moist chamber, the plate was incubated during 5 to 10 
minutes at room temperature, and the reaction was stopped with the addition of sulfuric acid. The reading was 
performed by a spectrophotometer of microplates (ELISA reader). The inhibition of 50% of the parasite growth 
(IC50) was determined by dose-response curves, through linear regression, using the program Origin. 
Citotoxicity assays in vitro on HepG2 cells
Human cell line HepG2 was cultured as recommended (CALVO-CALLE et al., 1994).  Cells were cultured in 
culture bottles, with culture medium (RPMI) and gentamicin. They were maintained in an incubator and its medium 
was replaced each two days. For the preparation of the plates, they were washed with incomplete medium and 
treated in tripsin-EDTA and incubated for the detachment of the cells from the culture bottle. After, the complete 
RPMI medium was added, followed by centrifugation at room temperature. The supernatant was discarded and the 
sediment resuspended in RPMI. After the preparation of the plates was added MTT (Sigma Aldrich) in the plates 
(DENIZOT; LANG, 1986). After incubation with MTT, supernatant was withdrawn and the dye at the bottom of 
the wells diluted with DMSO in a volume of 100μL/well. The microplates were read by an ELISA reader using a 
filter of 570 nm. The Minimum Lethal Dose of 50% of cells (MLD50) was also determined by the program Origin 
(OriginLab Corporation, Northampton, MA, EUA). 
Selectivity Index 
The Selectivity Index (SI) was calculated as a quotient of the MLD50 and IC50 values. If the SI was lower than 10, 
the extract was considered toxic; if the value was higher than 10, it was considered non- toxic (WENIGER et al., 2001).
3 Results and Discussion
All of the extracts assayed in this study exhibited antiplasmodial activities to some degree (Table 1). . Despite 
its high antiplasmodial activity, the chloroform extract (IC50 = 3.97 μg/mL) also showed great toxicity for the hu-
man cell line HepG2 (MLD50 = 18.12 μg/mL) (Table 1). However, the subsequent fractioning of this extract will be 
needed in order to assess the cytotoxic and antiplasmodial activities of its molecules, so one can verify whether 
the molecule presenting the highest antiplasmodial activity in this extract is also the main cause for the toxicity 
observed towards HepG2 cells. The extract that presented the best overall activity was the methanolic extract (SI 
= 18.97), despite it did not present neither the highest antiplasmodial activity nor the lower citotoxicity (Figure 1)
Table 1 - IC50, MLD50 and SI of C. leprosum flower extracts
Drug IC50 (μg/mL) MLD50 (μg/mL) SI RESULT
CLCrE 25.25 246.74 9.77 Inactive/Toxic
CLHE 12.20 168.89 13.84 Active/Non toxic
CLClE 3.97 18.12 4.56 Inactive/Toxic
CLEAE 11.46 123.66 10.79 Active/Non toxic
CLME 5.89 111.74 18.97 Active/Non toxic
CQ 0.04 297 7425 Active/Non toxic
IC50: Concentration causing 50% inhibition, MLD50 : Dose lethal to 50% of the population
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Figure 1 - Dose-response relationship curve of the methanolic extract (the extract presenting the higher SI) of the 
antiplasmodial (a) and citotoxicity (b) tests, respectively. 
Most of the pharmacological studies of C. leprosum report activities against non-infectious pathological pro-
cesses, such as neurodegenerative diseases (FACUNDO et al., 2005), ulceration (NUNES et al., 2009) and snake 
venom intoxication (FERNANDES et al., 2014). However, in a study performed by Teles and co-workers (2011), 
where from the fruits of C. leprosum were tested the ethanolic extract and a lupane, an antileishmanial activity 
was reported. The ethanolic extract showed an IC50 of 24.8 μg/mL. This result was similar to that of our study, in 
which the crude extract, also extracted with ethanol, obtained an IC50 of 25.70 μg/mL. The lupane exhibited an IC50 
of 3.3 μg/mL. The ethanolic extract was tested on a 25 μg/mL concentration and the lupane was tested on a 5 μg/
mL for citotoxicity. On these concentrations, neither the extract nor the lupane were toxic (TELES et al., 2011). The 
citotoxicity result of the ethanolic extract for Leishmania is also in agreement with our work. Further studies using 
the lupane against Leishmania were carried out for investigation of the activity of a liposomal formulation carrying 
the substance (BARROS et al., 2013) and for its interference in amastigote replication inside mammal cells, as well 
as investigation of its action mechanism through bioinformatics tools (TELES et al., 2015). This study, therefore, 
contributes to the understanding of the antiprotozoal activites of C. leprosum. 
      Species of the genus Combretum have already been investigated in respect to its pharmacological activities 
against non-infectious and infectious diseases, including antiplasmodial activities for some of these species (LIMA 
et al., 2012; ROY et al., 2014). Furthermore, some of them are used in traditional medicine to treat malaria and fever 
(TABUTI, 2008; TRAORE et al., 2013; DIARRA et al., 2015; AGBOEKA e al., 2016). The activity of our methanolic 
extract (IC50= 5.89 μg/mL) was similar to that presented by C. molle methanolic extract (IC50= 5.7 μg/mL), which was 
extracted from its leaves. The citotoxicity value was significantly different (MLD50= 40.3 μg/ml in K562S human 
monocyte cell line), possibly due to the use of a different cell line (GANSANÉ et al., 2009).
      An acetonic eluate, extracted from the bark of the stem of Combretum molle showed great activity against 
erythrocytic forms of P. falciparum, presenting an IC50 of 8.17 μg/mL. The citotoxicity of this extract in KB cells was 
86 μg/mL (MLD50), resulting in an SI of 10.5 (ASRES et al., 2001). In a study done by Moosophon and coworkers, 
four flavanes isolated from the stems of Combretum griffithii showed the following antiplasmodial activities (15.74, 
13.04, 9.66, and 14.45 μg/mL of IC50), although it’s respective toxicities to cell lines were significantly high. A di-
chloromethane extract of C. sericum leaves resulted in a low IC50 (9μg/ml) (MOOSOPHON et al., 2013). Niass and 
co-workers (2016) tested three medicinal plants, amongst them, Combretum glutinosum, against P. falciparum. Five 
extracts from this plant were assayed (ethyl acetate, IC50 = 41 μg/mL ; diethyl ether, IC50 = 65 μg/mL ; chloroform, 
IC50 = 38 μg/mL ; metanol, IC50 = 45 μg/mL, and methanol/water, IC50 = 35 μg/mL ), of which none of them resulted 
in an IC50 lower than 10 μg/mL.
      The ethanolic extract of the leaves of C. molle presented an IC50 value of 25 μg/mL, being very similar to 
the IC50 value of the crude extract of our work (25.25 μg/mL) (TRAORÉ-COULIBALY et al., 2013). Another study 
performed in 2013 with medicinal plants of Burkina Faso, in which are included Combretum collinum, showed very 
promising results. A chloroform extract obtained from the leaves of this species resulted in an IC50 = 0.2 μg/mL, 
with a SI = 140. An extract containing only alkaloids, extracted with chloroform resulted in an IC50 = 0.4 μg/mL 
and a SI of 113. 6 (SANON et al., 2013). These studies show the genus has a great pharmacological potential to be 
explored in the antimalarial therapy.
      Although the isolation of an active principle was not carried out, it is likely that the molecule presenting 
the highest antiplasmodial activity is a triterpene, since compounds of this class have several studies reporting its 
antiplasmodial activities (NOGUEIRA; LOPES, 2011; RAMALHETE et al., 2011; RAMALHETE et al., 2014) and this 
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chemical class seems to be the most abundant in species of the genus Combretum (DAWE et al., 2013) and in the 
species C. leprosum (FACUNDO et al., 1993; FACUNDO et al., 2008). Triterpenes that were isolated from the genus 
Combretum also showed activities against another microorganisms, like fungi (BISOLI et al., 2008), bacteria (ANGEH 
et al., 2007a; ANGEH et al., 2007b; SONGCA, RAMURAFHI; OLUWAFEMI, 2013), viruses (ASRES; BUCAR, 2005) 
and other species of parasites (TELES et al., 2011; HAAVIKO et al., 2014). 
4 Conclusions
The species C. leprosum has active substances against P. falciparum W2 strain in vitro, and despite the highest 
antiplasmodial activity was presented by the chloroform extract, it also showed high toxicity towards the human 
cell line HepG2. However, only the subsequent fractioning of this extract can identify what substances are the cau-
ses for each of these effects identified in the present study. Within this context, new research is needed in order to 
improve the knowledge about the activity of the molecules of this plant, such as the isolation and characterization 
of the active principle and in vivo tests with the extracts and/or the isolated substance, aiming the identification of 
a new molecule with potential to be used in antimalarial therapy.
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